Thus, activation of a TSP1-mediated TGFβ1/Smads pathway plays an important role in marcovascular remodeling in T2DM, and valsartan may hold promise for blocking the pathway and ameliorating vascular fibrosis in diabetes. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.